Glenn Nanney, MD
Pain Medicine · Newburgh, INNPI 1679993000
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,630 of the $4,919 with a category attached, or 73.8%. It is spread thinly across 14 manufacturers, the largest accounting for just 23.7%. 2025 is the largest year on record at $1,986, 2.2 times the $918 reported in 2020.
Across 84 payments — averaging $58.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$1K
- Medtronic$1K
- SPR Therapeutics, Inc$993
- Nevro Corp.$743
- Stimwave Technologies Incorporated$282
- AbbVie$162
- plus $487 from 8 others
What the payments were for
- Travel & lodging$1,28926%
- Food & beverage$3,63074%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical | 11 | $1,166 |
| Medtronic(2 entities) | 21 | $1,088 |
| SPR Therapeutics, Inc | 15 | $993 |
| Nevro Corp. | 15 | $743 |
| Stimwave Technologies Incorporated | 2 | $282 |
| AbbVie | 7 | $162 |
| Averitas Pharma Inc. | 6 | $122 |
| Medical Device Business Services, Inc. | 1 | $101 |
| Boston Scientific | 1 | $75 |
| Abbott | 1 | $73 |
| Avanos Medical | 1 | $38 |
| Vertos Medical, Inc. | 1 | $35 |
| Si-bone, Inc. | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,919 in reported general payments places this provider in the 60th percentile of 128 pain medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 13 | $8,982 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 293 | $6,808 |
| Fentanyl | 25 | $4,775 |
| Lidocaine | 17 | $2,330 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 75 | $1,657 |
| Gabapentin | 120 | $889 |
| Pregabalin | 34 | $779 |
| Duloxetine Hcl | 47 | $698 |
| Meloxicam | 26 | $608 |
| Naloxone Hcl | 12 | $577 |
| Tramadol Hcl | 59 | $342 |
| Tizanidine Hcl | 34 | $268 |
| Methocarbamol | 14 | $133 |
| Amitriptyline Hcl | 16 | $125 |
| Cyclobenzaprine Hcl | 15 | $120 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Newburgh
- Derron WilsonCarmel$616K
- Kevin MacadaegCarmel$337K
- Andrew TrobridgeMuncie$253K
- Meredith LanghorstFishers$233K
- Abhishek DasMishawaka$186K
- Rajiv TewariFishers$140K
- John SwoffordIndianapolis$127K
- Neal ColemanMuncie$38K
- Matthew DevriesLafayette$37K
- Amer KaziGranger$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.